Clinical Trial Update: Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment

View source ↗

Summary

Clinical trial update describing the OPTin organotypic platform to guide treatment decisions for patients with solid tumors/cancer, currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Snippet

Sponsor: China Medical University Hospital | Conditions: Cancer Patients With Solid Tumors, Cancer (Advanced Stage) | Status: ACTIVE_NOT_RECRUITING